UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

Clinical infectious diseases, 2013-08, Vol.57 (4), p.524-531

2013

Volltextzugriff (PDF)

Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients

Clinical infectious diseases, 2008-11, Vol.47 (10), p.1298-1304

2008

Volltextzugriff (PDF)

Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity

Antibiotics (Basel), 2019-03, Vol.8 (1), p.24

2019

Volltextzugriff (PDF)

Substantial Diversity in Cocirculating Omicron Lineages in Hospital Setting, Porto Alegre, Brazil

Emerging infectious diseases, 2023-12, Vol.29 (12), p.2583-2586

2023

Volltextzugriff (PDF)

Comparison of Vancomycin assays in patients undergoing hemodialysis

The Brazilian journal of infectious diseases, 2024-09, Vol.28 (5), p.103869, Article 103869

2024

Volltextzugriff (PDF)

Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Volltextzugriff (PDF)

Urgent need for evaluation of point-of-care tests as an RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients

Epidemiology and infection, 2021, Vol.149, p.e35-e35, Article e35

Zavascki, Alexandre P

2021

Volltextzugriff (PDF)

Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients

CPT: pharmacometrics and systems pharmacology, 2021-12, Vol.10 (12), p.1525-1537

2021

Volltextzugriff (PDF)

A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol

Infectious diseases and therapy, 2024-01, Vol.13 (1), p.237-250

2024

Volltextzugriff (PDF)

Colistin versus colistin plus meropenem for severe infections

The Lancet infectious diseases, 2018-05, Vol.18 (5), p.493-494

Zavascki, Alexandre P

2018

Volltextzugriff (PDF)

Which trial do we need? One or two antimicrobials with anti-pseudomonal activity for the empirical treatment of Ventilator-associated pneumonia due to Gram-negative bacteria

Clinical microbiology and infection, 2023-11, Vol.29 (11), p.1364-1366

2023

Volltextzugriff (PDF)

Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection

International journal of antimicrobial agents, 2019-02, Vol.53 (2), p.152-157

2019

Volltextzugriff (PDF)

Clinical Use of Polymyxin B

Polymyxin Antibiotics: From Laboratory Bench to Bedside, 2019-01, Vol.1145, p.197-218

2019

Volltextzugriff (PDF)

Clinical usefulness of tomographic standards for COVID-19 pneumonia diagnosis: Experience from a Brazilian reference center

The Brazilian journal of infectious diseases, 2020-11, Vol.24 (6), p.524-533

2020

Volltextzugriff (PDF)

Current status of Pseudomonas aeruginosa vaccine

Current pharmaceutical biotechnology, 2013-11, Vol.14 (11), p.951-959

2013

Volltextzugriff (PDF)

Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis

The Brazilian journal of infectious diseases, 2018-01, Vol.22 (1), p.51-54

2018

Volltextzugriff (PDF)

Performance of polymyxin B Etest in a setting of high prevalence of KPC-producing Klebsiella pneumoniae

Journal of global antimicrobial resistance., 2020-09, Vol.22, p.40-42

2020

Volltextzugriff (PDF)

Can ceftolozane–tazobactam treat nosocomial pneumonia?

The Lancet infectious diseases, 2019-12, Vol.19 (12), p.1266-1267

2019

Volltextzugriff (PDF)

Double-, single- and none-carbapenem-containing regimens for the treatment of carbapenem-resistant Enterobacterales (CRE) bloodstream infections: a retrospective cohort

Journal of antimicrobial chemotherapy, 2022-10, Vol.77 (11), p.3118-3125

2022

Volltextzugriff (PDF)

Combination therapy for carbapenem-resistant Gram-negative bacteria

Expert review of anti-infective therapy, 2013-12, Vol.11 (12), p.1333-1353

2013

Volltextzugriff (PDF)

Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Volltextzugriff (PDF)

Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium

International journal of antimicrobial agents, 2014-04, Vol.43 (4), p.349-352

2014

Volltextzugriff (PDF)

Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B

Antimicrobial agents and chemotherapy, 2016-04, Vol.60 (4), p.2443-2449

2016

Volltextzugriff (PDF)

Vancomycin MIC for Methicillin-Resistant Coagulase-Negative Staphylococcus Isolates: Evaluation of the Broth Microdilution and Etest Methods

Journal of Clinical Microbiology, 2010-12, Vol.48 (12), p.4652-4654

2010

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(125)

Publikationsform

Artikel
(133)
Berichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(100)
Science & Technology
(100)
Humans
(81)
Infectious Diseases
(70)
Microbiology
(50)
Pharmacology & Pharmacy
(40)
Male
(29)
Anti-Bacterial Agents - Pharmacology
(27)
Female
(27)
Microbial Sensitivity Tests
(24)
Middle Aged
(23)
Adult
(21)
Antibiotics
(20)
Polymyxin B
(20)
Aged
(18)
Mortality
(18)
Colistin
(16)
Polymyxins
(15)
Anti-Bacterial Agents - Therapeutic Use
(14)
Beta-Lactamases - Genetics
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients

Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity

Substantial Diversity in Cocirculating Omicron Lineages in Hospital Setting, Porto Alegre, Brazil

Comparison of Vancomycin assays in patients undergoing hemodialysis

Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?

Urgent need for evaluation of point-of-care tests as an RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients

Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients

A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol

Colistin versus colistin plus meropenem for severe infections

Which trial do we need? One or two antimicrobials with anti-pseudomonal activity for the empirical treatment of Ventilator-associated pneumonia due to Gram-negative bacteria

Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection

Clinical Use of Polymyxin B

Clinical usefulness of tomographic standards for COVID-19 pneumonia diagnosis: Experience from a Brazilian reference center

Current status of Pseudomonas aeruginosa vaccine

Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis

Performance of polymyxin B Etest in a setting of high prevalence of KPC-producing Klebsiella pneumoniae

Can ceftolozane–tazobactam treat nosocomial pneumonia?

Double-, single- and none-carbapenem-containing regimens for the treatment of carbapenem-resistant Enterobacterales (CRE) bloodstream infections: a retrospective cohort

Combination therapy for carbapenem-resistant Gram-negative bacteria

Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B

Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium

Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B

Vancomycin MIC for Methicillin-Resistant Coagulase-Negative Staphylococcus Isolates: Evaluation of the Broth Microdilution and Etest Methods

Suchergebnisse filtern